Medscape July 15, 2024
Kaila Trawitzki was diagnosed with long COVID in November 2020 and, since then, has never recovered. The Sacramento, California, software engineering consultant said her ongoing symptoms, as well as the cost and risk for travel, make most onsite clinical research trials off limits.
But last year, when scientists at Yale University, New Haven, Connecticut, started recruiting patients for a long COVID treatment trial that would be conducted remotely rather than on site, she signed up immediately. “Knowing I could do it from home was really appealing to me,” said Trawitzki.
As many as 17 million people in the United States currently have long COVID, yet experts say trials have been slow to enroll patients, in part because traveling to central...
Today's Sponsors
Today's Sponsor